MACROGENICS INC 4
Accession 0001209191-13-048778
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 8:24 PM ET
Size
44.6 KB
Accession
0001209191-13-048778
Insider Transaction Report
- Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying)
- Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying)
- Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying)
- Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote)
- Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying)
- Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying)
- Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying)
- Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying)
- Conversion
Common Stock
2013-10-16+962,819→ 962,819 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+615,284→ 1,578,103 total(indirect: See Footnote) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−2,448→ 0 total(indirect: See Footnote)→ Common Stock (2,448 underlying) - Conversion
Common Stock
2013-10-16+295,494→ 1,873,597 total(indirect: See Footnote) - Conversion
Series A-1 Convertible Preferred Stock
2013-10-16−12,001,000→ 0 total(indirect: See Footnote)→ Common Stock (962,819 underlying) - Conversion
Series C Convertible Preferred Stock
2013-10-16−5,547,611→ 0 total(indirect: See Footnote)→ Common Stock (295,494 underlying) - Conversion
Common Stock
2013-10-16+32,671→ 1,906,268 total(indirect: See Footnote) - Conversion
Common Stock
2013-10-16+2,448→ 1,908,716 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2013-10-16−10,131,856→ 0 total(indirect: See Footnote)→ Common Stock (615,284 underlying) - Exercise of In-Money
Series D-2 Convertible Preferred Stock Warrant to buy
2013-10-16−46,005→ 0 total(indirect: See Footnote)Exercise: $12.24Exp: 2013-10-16→ Series D-2 Convertible Preferred Stock (2,448 underlying) - Conversion
Series D-2 Convertible Preferred Stock
2013-10-16−613,402→ 0 total(indirect: See Footnote)→ Common Stock (32,671 underlying)
Footnotes (10)
- [F1]Each share of Series A-1 Convertible Preferred Stock converted into approximately 0.0802 of a share of Common Stock without payment of further consideraton upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F10]Immediately.
- [F2]These securities are held as follows: 928,647 by InterWest Partners VIII, LP ("IW8"), 7,521 by InterWest Investors VIII, LP ("II8") and 26,651 by InterWest Investors Q VIII, LP ("IIQ8") (collectively, the "InterWest Funds"). InterWest Management Partners VIII, LLC ("IMP8") is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
- [F3]Each share of Series B Convertible Preferred Stock converted into approximately 0.0607 of a share of Common Stock without payment of further consideraton upon closing of the Issuer's initial public offering. The shares had no expiration date.
- [F4]These securities are held as follows: 593,566 by IW8, 4,737 by II8 and 16,981 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
- [F5]Each share of Series C Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock converted into approximately 0.0533 of a share of Common Stock without payment of further consideraton upon closing of the Issuer's initial public offering. The shares had no expiration date.
- [F6]These securities are held as follows: 285,064 by IW8, 2,275 by II8 and 8,155 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
- [F7]These securities are held as follows: 31,519 by IW8, 251 by II8 and 901 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
- [F8]Upon exercise, each Series D-2 Convertible Preferred Warrant converted into an equal number of shares of Series D-2 Convertible Preferred Stock. Had the warrants not been exercised, they would have expired upon the closing of the initial public offering. Upon the closing of the Issuer's initial public offering each share of Series D-2 Convertible Preferred Stock then converted into approximately 0.0533 of a share of Common Stock without payment of further consideration. The shares of Series D-2 Convertible Preferred Stock had no expiration date.
- [F9]These securities are held as follows: 2,363 by IW8, 18 by II8 and 67 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
Issuer
MACROGENICS INC
CIK 0001125345
Related Parties
1- filerCIK 0001125345
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 8:24 PM ET
- Size
- 44.6 KB